Tissue tolerance: a distinct concept to control acute GVHD severity.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Blood

• Publication date

  2017-03-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/blood-2016-09-740431PMID 28153825PMCID PMC5374290
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Opposing Effects of Fasting Metabolism on Tissue Tolerance in Bacterial and Viral Inflammation.

  2016cited by this paper
• Gut microbiota, metabolites and host immunity

  2016cited by this paper
• Controlled, Randomized, Open-Label Trial of Risk-Stratified Corticosteroid Prevention of Acute Graft-Versus-Host Disease After Haploidentical Transplantation.

  2016cited by this paper
• Gut microbiome derived metabolites modulate intestinal epithelial cell damage and mitigate Graft-versus-Host Disease

  2016cited by this paper
• Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice

  2016cited by this paper
• PRKDC mutations associated with immunodeficiency, granuloma, and autoimmune regulator-dependent autoimmunity.

  2015cited by this paper
• NLRP6 in Host Target Tissues Exacerbates Graft-Versus-Host Disease

  2015cited by this paper
• Modulation of immune development and function by intestinal microbiota.

  2014cited by this paper
• Tissue damage control in disease tolerance.

  2014cited by this paper
• Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells

  2013cited by this paper
• Graft-versus-host disease disrupts intestinal microbial ecology by inhibiting Paneth cell production of α-defensins.

  2012cited by this paper
• Disease Tolerance as a Defense Strategy

  2012cited by this paper
• Tolerance of infections.

  2012cited by this paper
• Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation

  2012cited by this paper
• Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft versus host disease.

  2012cited by this paper
• Advances in graft-versus-host disease biology and therapy

  2012cited by this paper
• Intestinal homeostasis and its breakdown in inflammatory bowel disease

  2011cited by this paper
• The Wnt agonist R-spondin1 regulates systemic graft-versus-host disease by protecting intestinal stem cells

  2011cited by this paper
• Tissue-based class control: the other side of tolerance

  2011cited by this paper
• Reduced mortality after allogeneic hematopoietic-cell transplantation.

  2010cited by this paper
• An Essential Role for XBP-1 in Host Protection against Immune Activation in C. elegans

  2010cited by this paper
• The Coevolution of Virulence: Tolerance in Perspective

  2010cited by this paper
• Accommodation in renal transplantation: unanswered questions

  2010cited by this paper
• Two ways to survive infection: what resistance and tolerance can teach us about treating infectious diseases

  2008cited by this paper
• A central role for free heme in the pathogenesis of severe malaria: the missing link?

  2008cited by this paper
• Accommodation in organ transplantation

  2008cited by this paper
• Etanercept plus methylprednisolone as initial therapy for acute graft-versus-host disease.

  2007cited by this paper
• Friendly and dangerous signals: is the tissue in control?

  2007cited by this paper
• SNF1-related kinases allow plants to tolerate herbivory by allocating carbon to roots

  2006cited by this paper
• Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection.

  2006cited by this paper
• Akt and FOXO dysregulation contribute to infection-induced wasting in Drosophila.

  2006cited by this paper
• The Effect of α +-Thalassaemia on the Incidence of Malaria and Other Diseases in Children Living on the Coast of Kenya

  2006cited by this paper
• Keratinocyte growth factor ameliorates acute graft-versus-host disease in a novel nonmyeloablative haploidentical transplantation model

  2005cited by this paper
• Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology.

  2004cited by this paper
• Intestinal intraepithelial lymphocyte gamma delta-T cell-derived keratinocyte growth factor modulates epithelial growth in the mouse.

  2004cited by this paper
• Effect of up-front daclizumab when combined with steroids for the treatment of acute graft-versus-host disease: results of a randomized trial.

  2004cited by this paper
• Intestinal Intraepithelial Lymphocyte γδ-T Cell-Derived Keratinocyte Growth Factor Modulates Epithelial Growth in the Mouse1

  2004cited by this paper
• Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: comparison of grading systems.

  2002cited by this paper
• Genetic variation for disease resistance and tolerance among Arabidopsis thaliana accessions

  2002cited by this paper
• Colorectal Cancer in Mice Genetically Deficient in the Mucin Muc2

  2002cited by this paper
• Keratinocyte Growth Factor Separates Graft-Versus-Leukemia Effects From Graft-Versus-Host Disease

  1999cited by this paper
• Keratinocyte growth factor separates graft-versus-leukemia effects from graft-versus-host disease.

  1999cited by this paper
• Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation.

  1998cited by this paper
• Keratinocyte growth factor administered before conditioning ameliorates graft-versus-host disease after allogeneic bone marrow transplantation in mice.

  1998cited by this paper
• Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after matched unrelated donor marrow transplantation.

  1996cited by this paper
• Tacrolimus and Minidose Methotrexate for Prevention of Acute Graft- Versus-Host Disease After Matched Unrelated Donor Marrow Transplantation

  1996cited by this paper
• Treatment of moderate and severe acute GVHD after allogeneic bone marrow transplantation.

  1994cited by this paper
• Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prophylaxis of acute graft-versus-host disease.

  1993cited by this paper
• A retrospective analysis of therapy for acute graft-versus-host disease: secondary treatment.

  1990cited by this paper
• Treatment of moderate/severe acute graft-versus-host disease after allogeneic bone marrow transplantation: an analysis of clinical risk features and outcome.

  1990cited by this paper
• A randomized study of the prevention of acute graft-versus-host disease.

  1982cited by this paper
• Mitigation of secondary disease of allogeneic mouse radiation chimeras by modification of the intestinal microflora.

  1974cited by this paper
• Tolerance to Plant Disease

  1971cited by this paper
• Tolerance to Cereal Leaf Rusts.

  1958cited by this paper

• Recent advances in the pathophysiology of acute and chronic graft-versus-host disease.

  2026cites this paper
• Pathology associated with human CAR T cell administration in NOD.Cg-PrkdcscidIl2rgtm1Wjl/SzJ (NSG) mice: A retrospective analysis.

  2026cites this paper
• Challenges in GVHD and GVL after hematopoietic stem cell transplantation for myeloid malignancies.

  2025cites this paper
• Clinical and molecular landscapes of steroid-refractory graft-versus-host disease following hematopoietic stem cell transplantation: a narrative review

  2025cites this paper
• Microbiome dysbiosis and chemotherapy resistance in acute myeloid leukemia (AML)

  2025cites this paper
• Intestinal epithelium-derived IL-34 reprograms macrophages to mitigate gastrointestinal tract graft-versus-host disease.

  2025cites this paper
• Cellular therapies for the prevention and treatment of acute graft-versus-host disease.

  2025cites this paper
• Inflammatory Memory of Stem Cells: Implications for Hematological Diseases.

  2025cites this paper
• Fecal Microbiota Transfer in Acute Graft-versus-Host Disease following Allogeneic Stem Cell Transplantation

  2024cites this paper
• The graft versus leukemia effect: donor lymphocyte infusions and cellular therapy

  2024cites this paper
• Corticosteroids impair epithelial regeneration in immune-mediated intestinal damage

  2024cites this paper
• Autophagy differentially regulates tissue tolerance of distinct target organs in graft-versus-host disease models

  2024influential citation
• Oral inflammation and microbiome dysbiosis exacerbate chronic graft-versus-host disease

  2024cites this paper
• Oral Chronic Graft-Versus-Host Disease: Pathogenesis, Diagnosis, Current Treatment, and Emerging Therapies

  2024cites this paper
• Inflammation-induced epigenetic imprinting regulates intestinal stem cells.

  2024cites this paper
• Identification of a genetic region linked to tolerance to MRSA infection using Collaborative Cross mice

  2024cites this paper
• Fäkaler Mikrobiomtransfer bei GvHD und Komplikationen nach allogener Stammzelltransplantation: Ein vielversprechender Ansatz

  2024cites this paper
• Extracellular release of damaged mitochondria induced by prehematopoietic stem cell transplant conditioning exacerbates GVHD

  2024cites this paper
• The road to refractory graft-versus-host disease is paved with good intentions

  2024cites this paper
• Inflammatory memory restrains intestinal stem cell regeneration

  2023cites this paper
• Inhibition of RIP1 improves immune reconstitution and reduces GVHD mortality while preserving graft-versus-leukemia effects

  2023cites this paper
• Separation of GVL from GVHD -location, location, location

  2023cites this paper
• Allogeneic T cells cause acute renal injury after hematopoietic cell transplantation

  2023cites this paper
• Multimodal immune cell phenotyping in GI biopsies reveals microbiome-related T cell modulations in human GvHD

  2023cites this paper
• Identification of a genetic region in linked to tolerance to MRSA infection using Collaborative Cross mice

  2023cites this paper
• Fecal microbiota transplantation in hematopoietic cell transplant and cellular therapy recipients: lessons learned and the path forward

  2023cites this paper
• Novel insights into GVHD and immune reconstitution after allogeneic hematopoietic cell transplantation

  2023cites this paper
• Acute graft-versus-host disease

  2023cites this paper
• Phase II, Open-Label Clinical Trial of Urinary-Derived Human Chorionic Gonadotropin/Epidermal Growth Factor for Life-Threatening Acute Graft-Versus-Host Disease.

  2023cites this paper
• Extracellular release of damaged mitochondria induced by cytotoxic conditioning exacerbates

  2023cites this paper
• Comprehensive analysis of the prognosis, tumor microenvironment, and immunotherapy response of SDHs in colon adenocarcinoma

  2023cites this paper
• Engineered cellular immunotherapies in cancer and beyond

  2022cites this paper
• Current Prophylaxis and Treatment Approaches for Acute Graft-Versus-Host Disease in Haematopoietic Stem Cell Transplantation for Children With Acute Lymphoblastic Leukaemia

  2022cites this paper
• Operational tolerance after hematopoietic stem cell transplantation is characterized by distinct transcriptional, phenotypic, and metabolic signatures

  2022cites this paper
• New insight into pathophysiology and treatment of GVHD

  2022cites this paper
• Fu Fang Zhen Zhu Tiao Zhi Capsules Protect against Myocardial Ischemia by Inhibiting Cardiomyocyte Pyroptosis

  2022cites this paper
• Reg3α concentrations at day of allogeneic stem cell transplantation predict outcome and correlate with early antibiotic use

  2022cites this paper
• Milestones in acute GVHD pathophysiology

  2022cites this paper
• Mitochondrial complex II in intestinal epithelial cells regulates T cell-mediated immunopathology

  2021cites this paper
• National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2020 Etiology and Prevention Working Group Report.

  2021cites this paper
• Rearrangement of T Cell genome architecture regulates GVHD

  2021cites this paper
• Crosstalk Between Intestinal Microbiota Derived Metabolites and Tissues in Allogeneic Hematopoietic Cell Transplantation

  2021cites this paper
• Hematopoietic Dysfunction during Graft-Versus-Host Disease: A Self-Destructive Process?

  2021cites this paper
• IFN-λ therapy prevents severe gastrointestinal graft-versus-host disease

  2021cites this paper
• IFN-λ: paving the road toward tissue protection in GVHD.

  2021cites this paper
• The Pathophysiology and Treatment of Graft-Versus-Host Disease: Lessons Learnt From Animal Models

  2021cites this paper
• Graft-versus-host disease: a disorder of tissue regeneration and repair.

  2021cites this paper
• Insights from integrating clinical and preclinical studies advance understanding of graft-versus-host disease.

  2021cites this paper
• Spatial Multiomics Analysis Identifies SOCS1 as a Key Immune Checkpoint in T cell Tolerance Induction of HSCT

  2021cites this paper
• ON TOLERANCE TO PARASITIC INFECTIOUS DISEASES By

  2021cites this paper
• IFNλ Therapy Prevents Severe Gastrointestinal Graft-versus-Host Disease.

  2021cites this paper
• Three-dimensional genome structure and chromatin accessibility reorganization during in vivo induction of human T cell tolerance

  2020cites this paper
• How I treat steroid-refractory acute graft-versus-host disease.

  2020cites this paper
• A thermogenic fat-epithelium cell axis regulates intestinal disease tolerance

  2020cites this paper
• Mesenchymal stromal cells in hematopoietic cell transplantation.

  2020cites this paper
• New insights into the basic biology of acute graft-versus-host-disease.

  2020cites this paper
• How to Make an Immune System and a Foreign Host Quickly Cohabit in Peace? The Challenge of Acute Graft-Versus-Host Disease Prevention After Allogeneic Hematopoietic Cell Transplantation

  2020cites this paper
• New insights into the basic biology of acute graft-versus-host-disease.

  2020cites this paper
• Immunopathology and Biology Based Treatment of Steroid Refractory Graft-versus-Host Disease.

  2020cites this paper
• Mitochondrial Complex II In Intestinal Epithelial Cells Regulates T-cell Mediated Immunopathology

  2020cites this paper
• Donor and host B7-H4 expression negatively regulates acute graft-versus-host disease lethality.

  2019cites this paper
• Host NLRP6 exacerbates graft-versus-host disease independent of gut microbial composition

  2019cites this paper
• Achievement of Tolerance Induction to Prevent Acute Graft-vs.-Host Disease

  2019cites this paper
• Summary and Outlook on the Future Challenges of Allogeneic HSCT

  2019cites this paper
• Murine Models of Steroid Refractory Graft-versus-Host Disease

  2018cites this paper
• Acute Graft-Versus-Host Disease

  2018cites this paper
• Ruxolitinib protects skin stem cells and maintains skin homeostasis in murine graft-versus-host disease.

  2018cites this paper
• GVHD: biology matters.

  2018cites this paper
• Microbial metabolites and graft versus host disease

  2018cites this paper
• Acute Graft-versus-Host Disease.

  2018cites this paper
• GVHD: biology matters.

  2018cites this paper
• Disease tolerance: concept and mechanisms.

  2018cites this paper
• Accommodation and related conditions in vascularized composite allografts

  2017cites this paper